Cleared Traditional

K122129 - SPHYGMOCOR XCEL

K122129 is an FDA 510(k) clearance for SPHYGMOCOR XCEL, manufactured by Atcor Medical. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 121-day FDA review.

K122129 · Atcor Medical · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2012
Decision
121d
Days
Class 2
Risk

K122129 is an FDA 510(k) clearance for the SPHYGMOCOR XCEL. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Atcor Medical (West Ryde Nsw, AU). The FDA issued a Cleared decision on November 16, 2012 after a review of 121 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Atcor Medical devices

FDA 510(k) Submission Details - K122129

510(k) Number K122129 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 2012
Decision Date November 16, 2012
Days to Decision 121 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 125d · This submission: 121d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 567
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K122129.
NEXFIN MODEL 2
K122381 · Edwards Lifesciences, LLC · Apr 2013
APPS-HEALTH01
K122098 · Andon Health Co, Ltd. · Mar 2013
BP652N (HEM-6300-Z)
K123498 · Omron Healthcare, Inc. · Mar 2013
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K121372 · Andon Health Co, Ltd. · Sep 2012
HEM-7200-Z (BP742)
K121932 · Omron Healthcare, Inc. · Aug 2012
MICROLIFE WRIST WATCH BLOOD PREEURE MONITOR, BP3MO1-3P
K120430 · Microlife Intellectual Property GmbH · Aug 2012